Your browser doesn't support javascript.
loading
Effect of Irvingia gabonensis on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion.
Méndez-Del Villar, Miriam; González-Ortiz, Manuel; Martínez-Abundis, Esperanza; Pérez-Rubio, Karina G; Cortez-Navarrete, Marisol.
Afiliação
  • Méndez-Del Villar M; Institute of Experimental and Clinical Therapeutics, Physiology Department, Health Science University Center, University of Guadalajara , Guadalajara, Mexico .
  • González-Ortiz M; Institute of Experimental and Clinical Therapeutics, Physiology Department, Health Science University Center, University of Guadalajara , Guadalajara, Mexico .
  • Martínez-Abundis E; Institute of Experimental and Clinical Therapeutics, Physiology Department, Health Science University Center, University of Guadalajara , Guadalajara, Mexico .
  • Pérez-Rubio KG; Institute of Experimental and Clinical Therapeutics, Physiology Department, Health Science University Center, University of Guadalajara , Guadalajara, Mexico .
  • Cortez-Navarrete M; Institute of Experimental and Clinical Therapeutics, Physiology Department, Health Science University Center, University of Guadalajara , Guadalajara, Mexico .
J Med Food ; 21(6): 568-574, 2018 Jun.
Article em En | MEDLINE | ID: mdl-29336718
The aim of this study was to evaluate the effect of Irvingia gabonensis on metabolic syndrome (MetS), insulin sensitivity, and insulin secretion. A randomized, double-blind, placebo-controlled clinical trial was performed in 24 patients with MetS in accordance with the International Diabetes Federation criteria. Twelve patients received I. gabonensis (150 mg) twice a day during 90 days, and 12 patients received placebo. Glucose and insulin concentrations were measured during a 2-h oral glucose tolerance test. Also, lipid profile, creatinine, uric acid, and hepatic enzymes were determined. The area under the curve (AUC) of glucose and insulin, total insulin secretion, first phase of insulin secretion, and insulin sensitivity were calculated. Data were tested using non-parametric tests. The Ethics Committee approved the protocol. After I. gabonensis administration, significant decreases in waist circumference (WC) (94.0 ± 8.0 vs. 91.0 ± 8.2 cm, P < .01), glucose 90' (10.0 ± 2.5 vs. 8.6 ± 2.7 mmol/L, P < .05), glucose 120' (8.8 ± 2.4 vs. 7.6 ± 2.7 mmol/L, P < .05), triglycerides (2.5 ± 1.2 vs. 2.0 ± 1.1 mmol/L, P < .05), very low-density lipoproteins (VLDL) (0.5 ± 0.2 vs. 0.4 ± 0.2 mmol/L, P < .05), and AUC of glucose (694 ± 142 vs. 629 ± 172 mmol/L/min, P < .05) were found. Seven patients (58.3%) of the I. gabonensis group showed remission of MetS and two patients (16.7%) of the placebo group (P = .045). I. gabonensis lead to remission of MetS in 58.3% of the patients and significantly decreased WC, glucose 90', glucose 120', triglycerides, VLDL, and AUC of glucose.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Celulose / Síndrome Metabólica / Insulina Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Aspecto: Ethics Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Food Assunto da revista: CIENCIAS DA NUTRICAO / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Celulose / Síndrome Metabólica / Insulina Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Aspecto: Ethics Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Food Assunto da revista: CIENCIAS DA NUTRICAO / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos